Regulation & law · 31/07/2013Updated: 10/17/2026 · 1 min read
Johnson Matthey Pharmaceutical Materials, Inc. Files Notice of Registration with the U.S. Drug Enforcement Administration for Controlled Substances
Summary
Johnson Matthey Pharmaceutical Materials, Inc. has submitted a notice of registration to the U.S. Drug Enforcement Administration, indicating its intention to manufacture controlled substances, as required by law.